July 2, 2019
Japan Tissue Engineering’s (J-TEC) autologous cultured epidermis JACE became eligible for health coverage on July 1 for an additional indication of epidermolysis bullosa, the Fujifilm Group company said the same day. Epidermolysis bullosa is a genetic skin disorder characterized by...read more